Period of time： 2014年1期
Publisher： Springer Publishing Company
Founded in： 1983
Total resources： 32
ISSN： 0167-6997
Subject： R9 Pharmacy
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Investigational New Drugs,volume 23,issue 1
Menu
By Medina-Gundrum Leticia,Cerna Cesario,Gomez Lionel,Izbicka Elzbieta in (2005)
Investigational New Drugs,volume 23,issue 1 , Vol. 23, Iss. 1, 2005-01 , pp.
Access to resources
Recommend
Possible synergistic prostate cancer suppression by anatomically discrete pomegranate fractions
By Lansky Ephraim P.,Jiang Wenguo,Mo Huanbiao,Bravo Lou,Froom Paul,Yu Weiping,Harris Neil M.,Neeman Ishak,Campbell Moray J. in (2005)
Investigational New Drugs,volume 23,issue 1 , Vol. 23, Iss. 1, 2005-01 , pp.Inhibition of lymphocyte activation and function by the prenylation inhibitor L-778,123
By Si Ming-Sing,Reitz Bruce A.,Borie Dominic C. in (2005)
Investigational New Drugs,volume 23,issue 1 , Vol. 23, Iss. 1, 2005-01 , pp.By Marshall John L.,Kindler Hedy,Deeken John,Bhargava Pankaj,Vogelzang Nicholas J.,Rizvi Naiyer,Luhtala Taina,Boylan Stacy,Dordal Margaret,Robertson Philmore,Hawkins Michael J.,Ratain Mark J. in (2005)
Investigational New Drugs,volume 23,issue 1 , Vol. 23, Iss. 1, 2005-01 , pp.By Bence Aimee K.,Anderson Eric B.,Halepota Maqbool A.,Doukas Michael A.,DeSimone Phillip A.,Davis George A.,Smith Deborah A.,Koch Kevin M.,Stead Andrew G.,Mangum Steve,Bowen Carolyn J.,Spector Neil L.,Hsieh Showchien,Adams Val R. in (2005)
Investigational New Drugs,volume 23,issue 1 , Vol. 23, Iss. 1, 2005-01 , pp.By Bjarnason Georg,Charpentier Danielle,Wong Ralph,Goel Rakesh,Douglas Lynn,Walsh Wendy,Matthews Sarah,Dent Susan,Seymour Lesley in (2005)
Investigational New Drugs,volume 23,issue 1 , Vol. 23, Iss. 1, 2005-01 , pp.Phase I study of liposomal doxorubicin (Doxil) and cyclophosphamide in solid tumors
By El-Rayes Basil F.,Ibrahim Dina,Shields Anthony F.,LoRusso Patricia M.,Zalupski Mark M.,Philip Philip A. in (2005)
Investigational New Drugs,volume 23,issue 1 , Vol. 23, Iss. 1, 2005-01 , pp.By Goel R.,Chouinard E.,Stewart D. J.,Huan S.,Hirte H.,Stafford S.,Waterfield B.,Roach J.,Lathia C.,Agarwal V.,Humphrey R.,Walsh W.,Matthews S.,Seymour L. in (2005)
Investigational New Drugs,volume 23,issue 1 , Vol. 23, Iss. 1, 2005-01 , pp.Activity of gefitinib in advanced non-small-cell lung cancer with very poor performance status
By Chang Gee-Chen,Chen Kun-Chieh,Yang Tsung-Ying,Yin Ming-Chang,Lin Ching-Pei,Kuo Benjamin Ing-Tiau,Hsu Jeng-Yuan in (2005)
Investigational New Drugs,volume 23,issue 1 , Vol. 23, Iss. 1, 2005-01 , pp.By Latif Tahir,Wood Laura,Connell Cindy,Smith David C.,Vaughn David,Lebwohl David,Peereboom David in (2005)
Investigational New Drugs,volume 23,issue 1 , Vol. 23, Iss. 1, 2005-01 , pp.
Previous
Next